About Semma Therapeutics
Semma Therapeutics is a company based in Cambridge (United States) founded in 2015 was acquired by Vertex Pharmaceuticals in September 2019.. Semma Therapeutics has raised $158 million across 3 funding rounds from investors including Medtronic, Novartis and Vertex Pharmaceuticals. The company has 58 employees as of December 31, 2022. Semma Therapeutics has completed 1 acquisition, including CytoSolv. Semma Therapeutics operates in a competitive market with competitors including Kriya Therapeutics, Sana Biotechnology, Cellino, Adocia and Pendulum, among others.
- Headquarter Cambridge, United States
- Employees 58 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Semma Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$158 M (USD)
in 3 rounds
-
Latest Funding Round
$114 M (USD), Series B
Feb 26, 2019
-
Investors
Medtronic
& 12 more
-
Employee Count
58
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Vertex Pharmaceuticals
(Sep 03, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Semma Therapeutics
Semma Therapeutics has successfully raised a total of $158M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $114 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $114.0M
-
First Round
First Round
(31 Mar 2016)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Series B - Semma Therapeutics | Valuation | Eight Roads Ventures , Cowen | |
| Mar, 2017 | Amount | Series A - Semma Therapeutics | Valuation | T1D Fund |
|
| Mar, 2016 | Amount | Series A - Semma Therapeutics | Valuation | MPM Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Semma Therapeutics
Semma Therapeutics has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Novartis and Vertex Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Semma Therapeutics
Semma Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CytoSolv. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biotech company developing encapsulating cell technology for indications in cell therapy; acquired by Semma Therapeutics in 2015
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Semma Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Semma Therapeutics Comparisons
Competitors of Semma Therapeutics
Semma Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Sana Biotechnology, Cellino, Adocia and Pendulum, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Semma Therapeutics
Frequently Asked Questions about Semma Therapeutics
When was Semma Therapeutics founded?
Semma Therapeutics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Semma Therapeutics located?
Semma Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Semma Therapeutics a funded company?
Semma Therapeutics is a funded company, having raised a total of $158M across 3 funding rounds to date. The company's 1st funding round was a Series A of $44M, raised on Mar 31, 2016.
How many employees does Semma Therapeutics have?
As of Dec 31, 2022, the latest employee count at Semma Therapeutics is 58.
What does Semma Therapeutics do?
Semma Therapeutics engages in developing a cell therapy for Type 1 diabetes. It focuses on developing a cell therapy for patients who depend on insulin injections. It discovers a method to generate billions of functional, insulin-producing beta cells in the laboratory. These cells develop in islet-like clusters grown from stem cells. Initial preclinical work in animal models of diabetes has shown that transplantation of these cells is sufficient to control blood glucose levels and the company is currently planning to file an IND for this program. This breakthrough technology has been exclusively licensed (from Meltons lab) to Semma Therapeutics for the development of cell-based therapy for diabetes.
Who are the top competitors of Semma Therapeutics?
Semma Therapeutics's top competitors include Sana Biotechnology, Adocia and Pendulum.
How many acquisitions has Semma Therapeutics made?
Semma Therapeutics has made 1 acquisition, including CytoSolv.
Who are Semma Therapeutics's investors?
Semma Therapeutics has 13 investors. Key investors include Medtronic, Novartis, Vertex Pharmaceuticals, TD Securities, and Arch Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.